• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes.

作者信息

Ando Hirohiko, Yamaji Kyohei, Kohsaka Shun, Ishii Hideki, Wada Hideki, Yamada Sumio, Sawano Mitsuaki, Inohara Taku, Numasawa Yohei, Ikari Yuji, Amano Tetsuya

机构信息

Department of Cardiology, Aichi Medical University, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

Cardiovasc Interv Ther. 2022 Apr;37(2):243-247. doi: 10.1007/s12928-021-00832-0. Epub 2022 Jan 12.

DOI:10.1007/s12928-021-00832-0
PMID:35020153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753025/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/5da1b0da5a58/12928_2021_832_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/eb4728f2e751/12928_2021_832_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/1d85b364d3e8/12928_2021_832_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/1243a1b38c49/12928_2021_832_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/40c14fa02bd7/12928_2021_832_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/5da1b0da5a58/12928_2021_832_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/eb4728f2e751/12928_2021_832_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/1d85b364d3e8/12928_2021_832_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/1243a1b38c49/12928_2021_832_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/40c14fa02bd7/12928_2021_832_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180c/8926993/5da1b0da5a58/12928_2021_832_Fig5_HTML.jpg

相似文献

1
Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes.《2019年日本全国经皮冠状动脉介入治疗（J-PCI）注册报告：患者人口统计学特征及院内结局》
Cardiovasc Interv Ther. 2022 Apr;37(2):243-247. doi: 10.1007/s12928-021-00832-0. Epub 2022 Jan 12.
2
In-Hospital Outcomes After Percutaneous Coronary Intervention for Acute Coronary Syndrome With Cardiogenic Shock (from a Japanese Nationwide Registry [J-PCI Registry]).急性冠状动脉综合征伴心原性休克行经皮冠状动脉介入治疗的住院结局（来自日本全国注册研究[J-PCI 注册研究]）。
Am J Cardiol. 2019 May 15;123(10):1595-1601. doi: 10.1016/j.amjcard.2019.02.015. Epub 2019 Feb 22.
3
Impact of Institutional and Operator Volume on Short-Term Outcomes of Percutaneous Coronary Intervention: A Report From the Japanese Nationwide Registry.机构和术者量对经皮冠状动脉介入治疗短期结局的影响：来自日本全国登记的报告。
JACC Cardiovasc Interv. 2017 May 8;10(9):918-927. doi: 10.1016/j.jcin.2017.02.015.
4
Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry.日本经皮冠状动脉介入治疗的当代应用与趋势：J-PCI注册研究概述
Cardiovasc Interv Ther. 2020 Jul;35(3):218-226. doi: 10.1007/s12928-020-00669-z. Epub 2020 May 21.
5
Effect of Procedural Volume on In-Hospital Outcomes After Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease (from the Japanese National Clinical Data [J-PCI Registry]).慢性肾脏病患者经皮冠状动脉介入治疗后住院结局与操作量的相关性：来自日本国家临床数据（J-PCI 注册研究）
Am J Cardiol. 2022 Feb 15;165:12-18. doi: 10.1016/j.amjcard.2021.10.042. Epub 2021 Dec 7.
6
In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.经皮冠状动脉介入治疗冠状动脉旁路移植术的住院结局和栓塞保护装置的使用：来自日本全国登记处的见解。
Catheter Cardiovasc Interv. 2021 Sep;98(3):E356-E364. doi: 10.1002/ccd.29695. Epub 2021 Apr 16.
7
Variation in in-hospital mortality and its association with percutaneous coronary intervention-related bleeding complications: A report from nationwide registry in Japan.住院死亡率的变化及其与经皮冠状动脉介入治疗相关出血并发症的关系：来自日本全国登记处的报告。
PLoS One. 2021 Dec 13;16(12):e0261371. doi: 10.1371/journal.pone.0261371. eCollection 2021.
8
Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan.在 62737 例急性冠脉综合征患者中，与标准剂量氯吡格雷相比，使用低剂量普拉格雷对经皮冠状动脉介入治疗住院结局的影响：一项日本全国注册研究。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):231-238. doi: 10.1093/ehjcvp/pvz056.
9
Demographics and Outcomes of Percutaneous Coronary Intervention in Thailand: Data from Thai Percutaneous Coronary Intervention Registry.泰国经皮冠状动脉介入治疗的人口统计学和结果：来自泰国经皮冠状动脉介入治疗注册中心的数据。
J Med Assoc Thai. 2017 Mar;100(3):270-9.
10
An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.经皮冠状动脉介入治疗在透析患者中的概述：来自日本全国登记处的见解。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):E1-E8. doi: 10.1002/ccd.27986. Epub 2018 Nov 23.

引用本文的文献

1
Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024.2024年埃塞俄比亚亚的斯亚贝巴格桑德心脏与医学中心接受经皮冠状动脉介入治疗患者的临床特征与结局
Am J Cardiovasc Dis. 2025 Feb 15;15(1):29-38. doi: 10.62347/RIAQ1956. eCollection 2025.
2
Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes.冠状动脉粥样硬化的连续光学相干断层扫描评估与长期临床结局。
J Am Heart Assoc. 2024 Nov 5;13(21):e034458. doi: 10.1161/JAHA.123.034458. Epub 2024 Oct 22.
3
Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review.

本文引用的文献

1
Comparison between biodegradable- and durable-polymer everolimus-eluting stents in hemodialysis patients with coronary artery disease.生物可降解聚合物与耐用聚合物依维莫司洗脱支架在冠心病血液透析患者中的比较。
Cardiovasc Interv Ther. 2022 Jul;37(3):475-482. doi: 10.1007/s12928-021-00827-x. Epub 2021 Nov 24.
2
The Japanese Association of Cardiovascular Intervention and Therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan.日本心血管介入与治疗学会关于日本新冠疫情期间冠状动脉侵入性手术的立场声明。
Cardiovasc Interv Ther. 2021 Apr;36(2):139-144. doi: 10.1007/s12928-021-00767-6. Epub 2021 Mar 22.
3
经皮冠状动脉介入治疗后房颤患者的抗栓管理：一项临床综述。
J Arrhythm. 2024 Aug 8;40(5):1108-1114. doi: 10.1002/joa3.13128. eCollection 2024 Oct.
4
Gender Disparities in Japanese Interventional Cardiology: Outcomes of Female Operators in Percutaneous Coronary Interventions.日本介入心脏病学中的性别差异：女性操作者在经皮冠状动脉介入治疗中的结果
JACC Asia. 2024 Aug 20;4(9):674-683. doi: 10.1016/j.jacasi.2024.07.005. eCollection 2024 Sep.
5
Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS database.经皮冠状动脉介入治疗期间用药数量与慢性冠状动脉综合征患者不良事件的关系：CLIDAS数据库分析
Int J Cardiol Heart Vasc. 2024 Sep 12;54:101507. doi: 10.1016/j.ijcha.2024.101507. eCollection 2024 Oct.
6
Relationship between body mass index and clinical events in patients with atrial fibrillation undergoing percutaneous coronary intervention.体重指数与经皮冠状动脉介入治疗的心房颤动患者临床事件的关系。
PLoS One. 2024 Sep 19;19(9):e0309758. doi: 10.1371/journal.pone.0309758. eCollection 2024.
7
Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial Infarction.癌症、炎症及无标准风险因素对心肌梗死患者的影响
JACC Asia. 2024 May 28;4(7):507-516. doi: 10.1016/j.jacasi.2024.03.008. eCollection 2024 Jul.
8
Door-to-Balloon Time and Mortality in STEMI With Cardiogenic Shock: A Nationwide Registry.ST段抬高型心肌梗死合并心源性休克患者的门球时间与死亡率：一项全国性注册研究
JACC Asia. 2024 Apr 23;4(5):421-422. doi: 10.1016/j.jacasi.2024.03.002. eCollection 2024 May.
9
Cardiac arrest and post-discharge mortality in patients with myocardial infarction: A large-scale nationwide registry analysis.心肌梗死患者的心脏骤停与出院后死亡率：一项全国性大规模登记分析
Resusc Plus. 2024 May 3;18:100647. doi: 10.1016/j.resplu.2024.100647. eCollection 2024 Jun.
10
Differential Prognostic Impact of Risk-Prediction Models for Heart Failure in Acute Myocardial Infarction: The Original and Revised Heart Failure Time-Points.急性心肌梗死中心力衰竭风险预测模型的差异预后影响：原始和修订的心力衰竭时间点
J Clin Med. 2024 Apr 24;13(9):2501. doi: 10.3390/jcm13092501.
Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan　- Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease.
COVID-19 大流行期间在日本实施经皮冠状动脉介入治疗 - 日本心血管介入治疗协会心血管疾病全国调查报告。
Circ J. 2020 Nov 25;84(12):2185-2189. doi: 10.1253/circj.CJ-20-0708. Epub 2020 Sep 19.
4
Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry.日本经皮冠状动脉介入治疗的当代应用与趋势：J-PCI注册研究概述
Cardiovasc Interv Ther. 2020 Jul;35(3):218-226. doi: 10.1007/s12928-020-00669-z. Epub 2020 May 21.
5
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
6
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.《日本循环学会2018年急性冠状动脉综合征诊断与治疗指南》
Circ J. 2019 Apr 25;83(5):1085-1196. doi: 10.1253/circj.CJ-19-0133. Epub 2019 Mar 29.
7
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.